Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-044193
Filing Date
2025-05-15
Accepted
2025-05-15 16:06:38
Documents
69
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0241687-10q_oramed.htm   iXBRL 10-Q 715298
2 SHARE PURCHASE AGREEMENT, DATED AS OF APRIL 28, 2025, BY AND BETWEEN ORAMED LTD. ea024168701ex10-1_oramed.htm EX-10.1 158805
3 CONSULTING AGREEMENT BY AND BETWEEN ORAMED PHARMACEUTICALS INC. AND KNRY, LTD., ea024168701ex10-2_oramed.htm EX-10.2 114377
4 EMPLOYMENT AGREEMENT BY AND BETWEEN ORAMED LTD. AND MIRIAM KIDRON, ENTERED INTO ea024168701ex10-3_oramed.htm EX-10.3 128454
5 CERTIFICATION ea024168701ex31-1_oramed.htm EX-31.1 15983
6 CERTIFICATION ea024168701ex31-2_oramed.htm EX-31.2 15999
7 CERTIFICATION ea024168701ex32-1_oramed.htm EX-32.1 5770
8 CERTIFICATION ea024168701ex32-2_oramed.htm EX-32.2 5773
  Complete submission text file 0001213900-25-044193.txt   5730496

Data Files

Seq Description Document Type Size
9 XBRL SCHEMA FILE ormp-20250331.xsd EX-101.SCH 50238
10 XBRL CALCULATION FILE ormp-20250331_cal.xml EX-101.CAL 37631
11 XBRL DEFINITION FILE ormp-20250331_def.xml EX-101.DEF 246320
12 XBRL LABEL FILE ormp-20250331_lab.xml EX-101.LAB 450700
13 XBRL PRESENTATION FILE ormp-20250331_pre.xml EX-101.PRE 257900
71 EXTRACTED XBRL INSTANCE DOCUMENT ea0241687-10q_oramed_htm.xml XML 585702
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

EIN.: 980376008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35813 | Film No.: 25952806
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)